Analysis of international trade statistics shows that different groups of the European Union (EU) member countries reacted differently to a ban on imports of certain types of food products (hereinafter referred to as «sanctioned goods») by Russia in August 2014, which also implies a ban on transit traffic.

The pharmaceutical industry is a key partner in Europe’s fight against disease, developing new treatments and cures for patients across Europe. It is imperative that Europe remains a competitive destination for medical research and development by maintaining, sustaining and developing a predictable, robust regulatory and innovation-supportive incentives environment.